If you work in medical device labeling, you already know that 2026 has brought significant regulatory changes. Between the FDA's Quality Management System Regulation (QMSR) and mandatory EUDAMED modules in the EU, the rules around labeling have shifted dramatically. Cloud labeling software helps you navigate these requirements by centralizing your assets, automating approvals, and maintaining the audit trails that regulators expect. Kallik Veraciti gives medical device manufacturers a single platform to manage labels and artwork across global markets.

This blog walks you through everything you need to know about enterprise labeling and artwork management software for medical devices. You'll learn what cloud labeling software does, how to evaluate your options, and how to implement workflows that keep you compliant while accelerating your time to market.

 

Key Takeaways: Cloud Labeling Software for Medical Devices in 2026
 

• Cloud labeling software centralizes your medical device labeling assets, giving you a single source of truth across all markets and products.
• 21 CFR Part 11 and EU Annex 11 compliance requires audit trails, electronic signatures, and validated systems that cloud platforms can deliver.
• Automated approval workflows reduce label cycle times by eliminating email chains and enabling role-based reviews with full traceability.
• Kallik’s software helps medical device manufacturers reduce label change cycles by up to 70% while ensuring EU MDR and FDA compliance.
• Choosing the right cloud labeling software requires evaluating integration capabilities, validation support, and regulatory feature sets carefully.
   

What is Cloud Labeling Software for Medical Devices

Cloud labeling software is a platform that lets you create, manage, approve, and distribute medical device labels through a web-based system. Rather than storing files on local servers or sharing artwork through email, you access everything through a secure online environment. This approach centralizes all your labeling assets, from symbols and regulated phrases, to translations and artwork files – all in one location. Your team members access the same current versions regardless of their physical location. Changes propagate instantly across your entire product portfolio.

How Cloud Labeling Differs from On-Premise Solutions

Traditional on-premise labeling systems require you to install software on your own servers. You manage the hardware, handle security updates, and coordinate access for remote team members.

Cloud platforms eliminate that infrastructure burden. Your vendor hosts the system, manages security, and handles uptime. You log in through a browser and get to work. For medical device companies with facilities across multiple continents, this means your team in Asia can approve the same label that your regulatory specialist in Europe just updated and without VPN complications or server synchronization delays.

Core Capabilities of Cloud Labeling Platforms

Modern cloud labeling software typically includes several key functions. Asset management lets you store and organize all your labeling components. Workflow automation routes labels through predefined approval paths. Version control tracks every change with timestamps and user attribution.

Integration capabilities connect your labeling platform to other enterprise systems like PLM, ERP, and QMS. Reporting tools let you pull audit data quickly when regulators come calling. These features combine to create an end-to-end system that handles your entire label lifecycle.

Why Medical Device Manufacturers Need Cloud Labeling Software in 2026

The regulatory environment for medical device labeling has grown more demanding over the past several years. Cloud labeling software addresses these challenges directly by building compliance features into your daily workflows.

FDA QMSR and 21 CFR Part 11 Requirements

The FDA's transition to the Quality Management System Regulation (QMSR) aligns 21 CFR Part 820 with ISO 13485:2016. For your labeling operations, this means tighter requirements around documentation, traceability, and validated processes.

21 CFR Part 11 specifically governs electronic records and electronic signatures. Your cloud labeling system must capture who made each change, when they made it, and why.

Electronic signatures require two distinct identification components, typically a user ID and password. The system must link signatures to specific records and maintain complete audit trails that regulators can review.

EU MDR and IVDR Labeling Obligations

The EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have introduced extensive new labeling requirements. Your labels must now include specific symbols from EN ISO 15223-1:2021, Unique Device Identifiers (UDI), and detailed manufacturer information.

MDR Annex I Chapter III Section 23.2 lists every element that must appear on your device labels. Cloud labeling software helps you manage this complexity by storing approved phrases, symbols, and translations centrally. When regulations change, you can update affected content once and push changes across all relevant labels.

Managing Global Labeling Complexity

Medical device companies selling internationally face labeling requirements that vary by market. Language translations, country-specific symbols, and regional regulatory statements all need tracking and management.

A cloud platform gives you visibility across your entire portfolio. You can quickly identify which labels need updates when a regulation changes or when you enter a new market. This centralized approach prevents the inconsistencies that lead to compliance gaps and potential recalls.

Essential Features to Look for in Cloud Labeling Software

When evaluating cloud labeling software for your medical device organization, certain features distinguish platforms built for regulated industries from generic design tools.

Audit Trails and Electronic Records Management

Your system must generate computer-generated, time-stamped audit trails for every action that creates, modifies, or deletes a record. These trails should capture the user who performed the action, exactly what changed, and the reason for the change.

The audit trail must be protected from alteration or deletion. During regulatory inspections, you'll need to export this data in human-readable formats quickly. Look for systems that let you filter audit data by date range, user, asset, or batch number.

Electronic Signature Capabilities

21 CFR Part 11 requires that electronic signatures include two distinct identification components. The signature must display the signer's printed name, the date and time, and the meaning of the signature (such as "reviewed," "approved," or "author").

Authority checks should verify that users have permission to perform the specific step they're signing for. The system should detect and flag any unauthorized changes after signing. These controls ensure that your electronic approvals carry the same legal weight as handwritten signatures.

Role-Based Access Controls

Not everyone on your team needs the same access to your labeling system. Role-based access control lets you assign permissions based on job responsibilities. A designer might be able to create and edit artwork, while a regulatory specialist can only approve or reject.

This segregation of duties prevents conflicts of interest and ensures that critical actions require appropriate authorization. Session timeouts and automatic account lockouts add additional security layers. Regular access reviews help you identify and remove excessive privileges before they become compliance issues.

Workflow Automation and Approval Routing

Automated workflows route labels through predefined approval sequences without manual coordination. When a designer finishes a label, the system automatically notifies the next reviewer. Deadlines and reminders keep projects moving forward.

Parallel reviews let multiple stakeholders review simultaneously rather than waiting in sequence. This capability can significantly reduce your label cycle times. Kallik's medical device labeling software includes configurable workflows that adapt to your organization's specific approval requirements.

Integration with Enterprise Systems

Your labeling platform should connect with other business systems where product data lives. API availability lets you pull device attributes from your PLM or ERP automatically, eliminating double-entry and reducing transcription errors.

Integration with quality management systems ensures that CAPA activities and label changes stay synchronized. Legacy system compatibility matters if you're migrating from an existing platform. Evaluate how easily you can import your current label library and historical data.

Understanding Medical Device Labeling Compliance Requirements

Compliance requirements for medical device labeling span multiple regulatory frameworks. Understanding these requirements helps you configure your cloud labeling system appropriately.

FDA UDI System Requirements

The FDA's Unique Device Identification system requires that every medical device distributed in the United States carry a UDI. This identifier has two parts: the Device Identifier (DI), which identifies the specific version or model, and the Production Identifier (PI), which includes lot number, serial number, expiration date, and manufacturing date.

Your labels must include machine-readable formats like barcodes – either GS1 or HIBC standards depending on your chosen issuing agency. The UDI must also appear in human-readable plain text. Class III devices and implants have the most stringent requirements, while Class I devices have more limited obligations.

EU UDI Requirements Under MDR and IVDR

The European Union has implemented its own UDI requirements under MDR Article 27. Devices must carry UDI carriers on labels, and manufacturers must submit UDI data to the EUDAMED database as applicable modules become operational.

IVDR introduces similar requirements for in vitro diagnostic devices. The phased implementation timeline means different device classes face different compliance deadlines. Your labeling system needs to track these requirements and alert you when deadlines approach.

ALCOA+ Principles for Data Integrity

Regulators expect your electronic records to meet ALCOA+ standards. Data must be Attributable (traceable to a specific user), Legible (readable and accessible), Contemporaneous (recorded at the time of the activity), Original (preserved as originally captured), and Accurate (complete and error-free).

The "plus" adds Complete, Consistent, Enduring, and Available. Your cloud labeling system should enforce these principles automatically through its design. Audit trails address attribution, version control maintains originals, and backup systems ensure enduring availability.

Step-by-Step Guide to Implementing Cloud Labeling Software

Moving to a cloud labeling platform requires careful planning. This step-by-step approach helps you manage the transition while maintaining compliance throughout.

Step 1: Assess Your Current Labeling Process

Start by documenting how your labeling process works today. Map out every step from initial design request through final production approval. Identify who touches each label, where bottlenecks occur, and how long each stage typically takes.

Catalog your existing labeling asset (symbols, phrases, templates, and artwork files). Note where these assets currently live and how different team members access them. This inventory becomes your migration checklist later.

Step 2: Define Your Requirements and Evaluation Criteria

Based on your current state assessment, define what your new system must accomplish. Distinguish between must-have features and nice-to-have capabilities. Consider your regulatory requirements, team size, number of products, and geographic distribution.

Create a vendor evaluation checklist that covers compliance features, integration capabilities, validation support, and user experience. Include questions about the vendor's experience with medical device customers and their regulatory expertise.

Step 3: Evaluate Vendors and Select Your Platform

Request demonstrations from vendors on your shortlist. Watch for how their systems handle specific scenarios you face – mass label changes, multi-language management, or complex approval routing.

Ask about validation documentation. Vendors serving regulated industries should offer accelerator packages including user requirements specifications, functional requirements specifications, and installation qualification scripts. These documents speed your validation but don't replace your responsibility to validate the system in your intended use.

Step 4: Plan Your Implementation Phases

Break your implementation into manageable phases. Many organizations start with a pilot involving a limited product line or geographic region. This approach lets you work out issues before full rollout.

Define clear success criteria for each phase. Establish who owns the project, what resources they need, and how you'll handle issues that arise. Build in time for training and documentation at each stage.

Step 5: Migrate Your Existing Label Library

Migrating your existing labels and assets takes careful attention. Verify that every symbol, phrase, and artwork file transfers correctly. Check that version histories and approval records remain intact.

Some platforms offer AI-driven digitization that can accelerate this process. These tools read existing labels and extract components into structured, searchable formats. The investment pays off through faster updates and better reuse of approved content.

Step 6: Configure Workflows and User Permissions

Set up your approval workflows to match your organization's needs. Define roles and assign appropriate permissions. Configure notification rules so team members know when actions require their attention.

Test your workflows thoroughly before going live. Create test labels and route them through your full approval process. Verify that audit trails capture everything correctly and that signatures appear where required.

Step 7: Train Your Team and Document Procedures

Effective training covers both system operation and regulatory requirements. Users need to understand why certain controls exist, not just how to click through them. Role-specific training ensures that designers, reviewers, and administrators each know their responsibilities.

Document your standard operating procedures for the new system. Include step-by-step instructions for common tasks and guidance for handling exceptions. Keep this documentation accessible and update it when processes change.

Step 8: Validate Your System

System validation demonstrates that your software operates as intended and meets regulatory requirements. Following vendor documentation helps but doesn't eliminate your validation obligations. You must validate the system in your specific intended use.

A risk-based approach focuses validation effort where it matters most—systems that impact product quality and patient safety. Document your validation activities thoroughly. Maintain evidence that tests passed and that any deviations were addressed appropriately.

Step 9: Go Live and Monitor Performance

Plan your cutover carefully. Some organizations run parallel processes temporarily, using both old and new systems until confidence builds. Others switch completely at a defined date.

Monitor key metrics after going live. Track label cycle times, error rates, and user adoption. Address issues quickly and adjust workflows based on real-world experience. Schedule regular reviews to identify improvement opportunities.

Best Practices for Medical Device Labeling Workflow Automation

Automating your labeling workflows delivers the biggest benefits when you design them thoughtfully. These practices help you maximize efficiency while maintaining compliance.

Design Workflows Around Your Actual Process

Map your approval workflows to how decisions actually happen in your organization. Forcing an artificial sequence creates frustration and workarounds. If your regulatory and quality reviewers typically work in parallel, configure parallel review steps.

Build in escalation paths for when someone is unavailable. Define backup approvers and timeout rules that prevent single individuals from becoming bottlenecks. Test these edge cases before they happen in production.

Use Templates and Component Libraries

Templates and reusable components dramatically accelerate label creation. Build approved symbol libraries, standard phrase collections, and pre-validated layout templates. When designers start from approved building blocks, they spend less time on repetitive work and make fewer errors.

Kallik Veraciti manages regulated content including text, symbols, translations, and claims centrally. This ensures consistency across your product portfolio and simplifies updates when regulations change.

Implement Automated Quality Checks

Configure your system to check for common issues automatically. Barcode validation ensures scannability before labels reach production. Spelling and grammar checks catch typos. Symbol placement rules verify that required elements appear where regulations specify.

These automated checks complement human review rather than replacing it. They catch obvious problems early so reviewers can focus on substantive evaluation rather than proofreading.

Track Metrics and Continuously Improve

Measure what matters: average cycle time, number of revision rounds, on-time completion rates, and error detection at each stage. These metrics reveal where your process works well and where improvements would have the most impact.

Schedule periodic process reviews with your labeling team. Ask what's working, what's frustrating, and what they wish the system could do. Small adjustments based on real user feedback add up to significant improvements over time.

How Kallik Veraciti Supports Medical Device Labeling Compliance

Kallik has spent over 20 years helping medical device manufacturers manage labeling and artwork processes. The Veraciti platform addresses the specific challenges that regulated industries face.

Single Source of Truth for All Labeling Assets

Veraciti centralizes your symbols, phrases, translations, and artwork in one cloud-based repository. Every team member works from the same current versions. When you update a symbol, that change flows through to every label using it.

The platform's "where used" functionality lets you quickly identify every label affected by a change. This visibility is critical when regulations change or safety information requires updates across your portfolio.

Automated Artwork Generation and Mass Change Management

Kallik's automated artwork generation tools create compliant labels from your approved content and templates. When you need to make changes across hundreds or thousands of labels, mass change capabilities let you apply updates uniformly rather than editing each file individually.

Medical device companies report reducing label change cycles by up to 70% after implementing Veraciti. This acceleration comes from eliminating the manual coordination that slows traditional processes.

Built-In Compliance for EU MDR, FDA, and Global Regulations

Veraciti includes features specifically designed for regulatory compliance. Full audit trails track every action. Role-based approval flows ensure proper authorization. Electronic signatures meet 21 CFR Part 11 requirements.

The platform supports EU MDR, IVDR, FDA UDI, FDA 21 CFR 820, 21 CFR Part 11, and EU GMP Annex 11 compliance. This regulatory coverage helps you manage requirements across multiple markets from a single system.

Cloud-Native Architecture on AWS

Veraciti runs entirely on Amazon Web Services with extensive security and compliance certifications. Cloud-native design means you get 24/7 availability, automatic backups, and access from anywhere your team works.

This infrastructure eliminates the IT burden of managing servers and security updates internally. Your team focuses on labeling work rather than system administration.

Common Challenges in Medical Device Labeling and How to Overcome Them

Even with strong systems, medical device labeling presents ongoing challenges. Understanding common issues helps you address them proactively.

Managing Multi-Language Labels

Products sold in multiple countries require translated labels. Managing dozens of language versions creates version control complexity and increases the risk that translations fall out of sync with source content.

Cloud labeling platforms address this by linking translated content to source phrases. When you update the source, the system flags all translations for review. Centralized translation management ensures consistency and simplifies the coordination with translation vendors.

Handling Regulatory Changes Across Multiple Markets

Regulations evolve constantly. New symbol requirements, updated safety statements, or changed UDI obligations can affect large portions of your label portfolio.

Effective platforms give you tools to assess regulatory impact quickly. You can identify affected labels, plan your update sequence, and track progress toward compliance deadlines. Automated alerts notify you when regulatory changes require attention.

Coordinating Approvals Across Teams and Time Zones

Global organizations often have approvers in different locations. Time zone differences can add days to approval cycles if you're waiting for sequential reviews.

Configure your workflows to enable parallel reviews where possible. Set clear expectations for review turnaround times. Use automated reminders to keep projects moving. These practices minimize delays without compromising review quality.

Integrating Acquisitions and New Product Lines

Medical device companies frequently grow through acquisitions. Each acquired company brings its own labeling systems, processes, and asset libraries. Integrating these into a unified platform takes planning and execution.

Cloud platforms simplify this integration because they don't require local infrastructure at each facility. You can onboard new sites quickly and migrate their assets into your centralized system. Standardized processes then ensure consistency across your expanded organization.

Future Trends in Medical Device Labeling Technology

Labeling technology continues to evolve. Understanding emerging trends helps you make decisions that position your organization well for the future.

AI and Machine Learning in Label Management

Artificial intelligence is beginning to change how organizations manage labels. AI-driven digitization can read existing labels and extract content into structured formats, accelerating migration from paper or file-based systems.

Machine learning algorithms can detect anomalies in label content, identify potential compliance issues, and suggest improvements based on patterns in your data. These capabilities augment human reviewers rather than replacing their judgment.

Electronic Instructions for Use (eIFU)

EU Implementing Regulation 2025/1234 expanded the scope of devices eligible for electronic Instructions for Use. For many professional-use devices, you can now deliver IFU content electronically rather than printing paper inserts.

This shift offers environmental benefits and cost savings while improving information currency. Your labeling system should support eIFU workflows including QR code generation, website hosting, and paper fallback procedures for devices that still require physical IFUs.

Enhanced Supply Chain Integration

Greater integration between labeling systems and supply chain partners continues to develop. Contract manufacturers, packaging suppliers, and logistics providers increasingly expect digital connections that eliminate manual handoffs.

API-based integrations let you share approved label files and production data securely with partners. This connectivity reduces lead times and ensures that your supply chain prints labels from controlled, current specifications.

In Conclusion: Choosing the Right Cloud Labeling Software for Your Medical Device Organization

The right cloud labeling software becomes a strategic asset for your medical device organization. It accelerates your time to market, reduces compliance risk, and gives your team tools that make their work easier rather than harder.

Focus your evaluation on the features that matter for regulated industries: audit trails, electronic signatures, role-based access, and validated workflows. Look for vendors with genuine experience in medical device labeling – the regulatory nuances matter.

Consider how the platform will grow with you. Your product portfolio will change, regulations will evolve, and your organization will expand into new markets. Choose a partner committed to adapting their platform alongside these changes.

Cloud labeling software represents an investment in operational excellence. When you centralize your labeling assets, automate your workflows, and build compliance into your daily processes, you create a foundation that supports your business objectives while protecting patient safety.
 

Frequently Asked Questions About Cloud Labeling Software for Medical Devices in 2026

Every regulatory affairs professional knows the feeling. A new requirement lands, be it a UDI update, a revised CLP classification, or a market specific mandate, and what follows is a familiar scramble. Someone pulls together a list of affected products, another person starts working through label versions, and a chain of emails and approval requests begins that will take weeks, sometimes months, to resolve.

The instinct is to treat this as a resourcing problem and focus on more people, more hours, faster turnaround. But for most organizations operating across multiple markets with complex product portfolios, that approach has a ceiling and regulatory affairs teams hit it regularly. The real issue here isn't the regulation itself, but rather the labeling process underneath it, and if you’re looking to break out of this cycle, the only solution is to re-think your process.

The Regulatory Landscape Is Only Getting More Complex

The volume and pace of regulatory change affecting labeling is not slowing down. Medical device recall events in the US increased by 8.6% in 2024, rising from 975 events in 2023 to 1,059 – with Class I severity recalls reaching a 15 year high. While recalls have multiple causes, labeling errors and non-compliance remain persistent contributors across pharmaceutical and medical device sectors.

At the same time, the regulatory environment itself continues to expand. EU MDR and IVDR implementation continues to evolve, IDMP standards are reshaping how medicinal product information is structured and submitted, DSCSA serialization requirements remain a live operational challenge for pharmaceutical supply chains in the US, and markets across Latin America and Asia are progressively tightening their own labeling frameworks.

For regulatory affairs teams, this creates a structural problem as the regulations keep coming and the label variants keep multiplying. And the question of how quickly and accurately your organization can respond becomes a competitive and compliance issue simultaneously.

Why Document Centric Processes Break Under Regulatory Pressure

Most labeling operations in regulated industries were built on a document centric model. Label content lives inside Word documents, PDFs, InDesign templates etc., stored across shared drives, local folders, or legacy content management systems. Each label is its own discrete object, managed independently. This model may work for smaller businesses with low volume, but at scale, it becomes a serious bottleneck and could end up costing enterprises a lot more than just time.

Consider a straightforward scenario. A pharmaceutical company markets a product across 15 countries, each requiring its own label variant to reflect local regulatory content, language, and symbol requirements. Under IDMP, a change to the way a medicinal product's ingredients or indications are structured may require updates across every one of those variants. Under a document centric model, that means 15 separate files to locate, update, review, and re-approve with the very real risk that a version somewhere in the chain gets missed.

Research published in PMC found that labeling issues accounted for close to 15% of drug recalls reviewed in a cross sectional FDA study – a figure that reflects how often the label, rather than the product itself, becomes the compliance failure point. In document driven environments, the conditions for exactly that kind of failure are structurally built in.

The same pattern plays out across medical devices. Medical device labeling most often fails when it comes to missed translation updates, version mismatches, and documentation gaps, leading to shipping bottlenecks and audit issues. These are simply the result of a process that was not designed to handle regulatory change at speed.

The Difference Between Updating a Document and Changing a Data Asset

The shift that makes labeling processes genuinely adaptable is moving from managing documents to managing data.

In a data driven labeling model, label elements (regulated phrases, hazard statements, ingredient declarations, symbols, translations) exist as version controlled data assets held in a centralized system. A label is assembled from those assets rather than created from scratch each time.

Therefore, when a regulatory requirement changes, the response is simple. Instead of hunting down every label that contains the affected content and editing each one manually, you update the asset once. The system identifies every label where that asset appears – using functionality like Kallik's Where Used search – and the update becomes one simple, controlled and traceable click.

This might just sound like a faster version of the same process, but it is in fact a fundamentally different relationship between your team and regulatory change. The question shifts from "which labels do we need to fix and have we found them all?" to "we've updated the asset, now what does the system show us needs review?"

That distinction matters enormously when you are dealing with a time sensitive regulatory deadline, a market withdrawal risk, or a post market surveillance finding that requires urgent label correction.

Structured Data Is Also the Foundation AI Needs

Labeling data is also crucial when it comes to the use of AI tools. Regulatory affairs functions are being asked to evaluate AI solutions that promise to accelerate content generation, translation review, or regulatory submission drafting. Some of these tools have serious potential, but only if the structured, controlled and accurate data is there to begin with. 

For regulatory affairs teams evaluating AI adoption, this is key. The enterprises that will get the most from AI in labeling are those that have already built the structured data foundation to support it.

What a Regulation Ready Labeling Process Actually Looks Like

There is no single definition of a regulation ready labeling process, but certain characteristics show up consistently in organizations that handle regulatory change well.

• A single source of truth
• Built in approval workflows
• Full and accurate version history (key for meeting the requirements of 21 CFR Part 11 and EU GMP Annex 11)
• Asset search functionality
• Electronic signatures

These each allow organizations to stay regulation ready while reducing risk and operational friction.

Where to Start

For most regulatory affairs teams, the move toward a data driven labeling model begins with an honest assessment of where content currently lives, how change is managed today, and what the real cost of the current approach is in time, risk, and resource.

If your team is spending meaningful time on each regulatory update just locating and auditing affected labels before any actual updating has begun, that is a reasonable place to start the conversation.

Kallik’s leading enterprise labeling and artwork management platform was built to support exactly this kind of transition, giving regulatory affairs teams a centralized, structured platform for managing labeling content across markets, products, and regulatory frameworks. To learn more about how it works in practice, visit our How Kallik Works page or get in touch with our team at enquiries@kallik.com or fill in a form here.

Download the guide

Subscribe to our newsletter for all the latest label and artwork news

Medical device recalls rarely start with a design flaw. More often, they start with a typo. A wrong translation. A symbol that didn't update across every SKU. A UDI code that matched the batch record in one system but not another.

These are small, administrative errors — the kind that happen when teams are managing thousands of labels across multiple markets using manual processes and disconnected tools. And in an industry where the label is a regulatory control point, not just a piece of packaging, small errors carry serious consequences.

The numbers make that clear. Medical device recalls reached a four-year high in 2024, with 1,059 events recorded in the US alone, according to Sedgwick's 2025 State of the Nation Recall Index.

That figure represents an 8.6% increase on 2023. And while device failure was cited as the leading cause of recall events for the first time in over five years, labeling and mislabeling issues remained among the most common causes of medical device recalls in 2024.

According to McKinsey, a medical device manufacturer can expect an average 10% drop in share price following a single major recall event, with reputational damage contributing to serious, long-term value destruction. And that's before factoring in the direct costs: product replacement, regulatory remediation, legal fees, and the operational disruption of pulling stock from a global supply chain.

Why Labeling Errors Are So Hard to Catch

Most medical device manufacturers are managing labeling across a patchwork of systems with one tool for graphic design, another for translation management, spreadsheets for regulatory tracking, email chains for approvals. Data moves between these systems manually. Every time a UDI code is re-typed, a translated phrase is copied into a template, or a symbol is updated in one artwork file but not another, the risk of error compounds.

At low volumes, this is manageable. At scale though, with thousands of SKUs, dozens of markets, and multiple languages, it becomes unsustainable. A process that works for a handful of labels will buckle when the next major regulatory update lands.

The challenge is that regulatory updates are no longer occasional, isolated events with clear deadlines. We are now in a period of continuous regulatory change. EUDAMED activation, GS1 Sunrise 2027, the EU AI Act, PPWR — these aren't a sequence of one-off projects. They're converging simultaneously, each adding new data requirements, new symbols, new disclosures, and new digital links to labels that are already crowded.

The Hidden Risk of the "We'll Update It When We Have To" Approach

In a reactive labeling operation, every new regulation becomes a fire drill. Resources are diverted, production is paused, and teams work overtime to manually touch every affected piece of artwork. For a portfolio of hundreds or thousands of SKUs, that is a serious operational and compliance risk every time a requirement changes.

The more dangerous version of this problem is the error that goes undetected. A label update is made in one region but not cascaded globally. A new eIFU URL is added to some batches but links to an outdated document version. A symbol is updated in the master template but the change doesn't flow through to a specific SKU variant. In a manual workflow, there is no reliable mechanism to know what you've missed.

That's the recall you never saw coming. It surfaces during an audit, a market inspection, or a patient safety event.

What Regulatory Readiness Actually Looks Like

The organizations managing labeling most effectively have moved away from reactive, project-based workflows and toward what could be called permanent regulatory readiness. The shift is architectural, not just operational.

It starts with a single source of truth: a centralized, cloud-based repository where every phrase, symbol, translation, and regulatory element is stored as a controlled digital asset. When a requirement changes, it changes once, in one place, and flows automatically to every label that uses it. There is no manual re-typing, no version drift, no cascading review cycle across hundreds of individual files.

Paired with automated artwork generation, this approach means labels are assembled from pre-approved, rules-based components rather than built manually from scratch. The right content for the right market is applied automatically. Right-first-time becomes the standard, not the goal.

And when an auditor asks where a specific symbol, phrase, or UDI element appears across your global portfolio, you can answer in seconds rather than weeks.

The Cost of Inaction Is Already Rising

For teams still evaluating whether investment in end-to-end labeling software is justified, it's worth reframing the question. The cost of a labeling recall, in share price impact, remediation, regulatory scrutiny, and reputational damage, almost always exceeds the cost of the infrastructure that would have prevented it.

The medical device sector recorded a four-year high for recall events in 2024, and the regulatory environment driving those events is only becoming more complex. More markets, more requirements, more data on every label. The organizations that treat labeling as a strategic, automated function are building resilience. Those that don't are building risk.

Want to understand what this means for your labeling operation specifically? Our practical guide on futureproofing your medical device labeling process covers the key regulations to watch, the real cost of manual workflows, and what effective preparation looks like in practice.

Download the guide

Subscribe to our newsletter for all the latest label and artwork news

Why the next wave of regulatory change will put labeling and packaging under pressure.

Most medical device companies aren’t prepared for 2026 and they don’t realize it yet. Your labeling process could already be out of date, but you just haven’t been forced to prove it yet. As new regulations roll out across 2026, the gap between compliant systems and manual workflows is becoming harder to ignore.

For years, regulatory change followed a familiar pattern. A new rule would emerge, teams would mobilize, deadlines would loom, and eventually things would settle again. However, that model no longer applies as regulatory change is becoming continuous, overlapping, and increasingly data-driven.

In this blog, we break down the key medical device regulations to watch in 2026, what they mean for your labeling operations, and why preparation will define success. 

The Shift: From Regulatory Deadlines to Continuous Change

It's all about convergence now – multiple global initiatives, each with their own requirements, all landing at the same time. Together, they are reshaping how labeling works. Labels are now structured, data-linked, and expected to stay synchronized with regulatory systems in near real time. That creates a new operational reality and if your processes rely on manual updates, disconnected systems, or periodic reviews, the risk isn’t just inefficiency, it’s non-compliance.

Key Medical Device Regulations to Watch in 2026

Here are the major regulatory drivers that will directly impact labeling and packaging over the next 12–24 months.

EU MDR and IVDR (and EUDAMED rollout)

While MDR and IVDR are already in effect, 2026 marks a critical milestone with the full activation of EUDAMED modules. This introduces a new expectation: your physical label must match your digital regulatory data exactly. Every claim, warning, and identifier must align with what is submitted to the database.

For labeling teams, this means:

• Labels must act as a “digital twin” of regulatory submissions
• Any mismatch between artwork and EUDAMED data can trigger compliance issues
• Labeling must integrate more tightly with regulatory and product data systems
• This is a shift from document management to data synchronization.

UDI (Unique Device Identification) Expansion

UDI is now a global requirement, expanding across regions including the EU, US, China, and beyond. By 2026, even legacy devices in the EU must be fully registered. The impact on packaging is immediate:

• More identifiers and barcodes on every label
• Increased risk of clutter and layout constraints
• Greater need for consistency across systems

The UDI on the label must match what exists in regulatory databases, manufacturing systems, and supply chain records. Managing this manually at scale introduces significant risk.

eIFUs (Electronic Instructions for Use)

The move toward digital instructions continues to accelerate, particularly under EU 2021/2226 updates. This reduces paper but adds complexity:

• Labels must include persistent URLs or QR codes
• The linked IFU must always be the correct, approved version
• Version control becomes critical across languages and markets

For packaging teams, this introduces a new dependency: your label is now directly connected to live digital content. Any disconnect creates compliance exposure.

EU AI Act

The EU AI Act introduces new requirements for AI-enabled medical devices, with major implications for labeling. For high-risk systems:

• Labels and IFUs must clearly disclose the use of AI
• Detailed information about performance, limitations, and training data is required
• The AI version must align exactly with labeling and declarations

This creates a new challenge as software evolves quickly, but labeling processes typically do not. Keeping both in sync requires a more agile, data-driven approach.

GS1 Sunrise 2027

Although the deadline is 2027, 2026 is the year organizations need to act. GS1 Sunrise mandates the shift from traditional barcodes to 2D DataMatrix or QR codes. These codes carry significantly more data and can link to digital resources. For labeling and packaging:

• Artwork must be redesigned to accommodate 2D codes
• Legacy barcodes must be replaced across entire portfolios
• Labels must support richer, connected data

The scale of change is the real challenge here as thousands of SKUs require updating – often simultaneously.

PPWR (Packaging and Packaging Waste Regulation)

Sustainability is now regulated, not optional. The EU’s PPWR introduces:

• Standardized recycling labels and material identifiers
• New pictograms on packaging
• Increased pressure on label space and design

This adds another layer of mandatory content to already crowded labels, forcing teams to rethink layout, hierarchy, and clarity.

EU Battery Regulation

For devices containing batteries, new requirements introduce the concept of a “Battery Passport.” This includes:

• QR codes linking to sustainability and lifecycle data
• New labeling requirements for carbon footprint and recycling
• Additional coordination between product and packaging data

This is where regulatory overlap becomes visible. Battery labeling must align with MDR/IVDR requirements, often within the same constrained space.

Why This Matters: The Growing Risk of Manual Processes

Individually, each of these regulations is manageable. However, together, they create a level of complexity that manual processes cannot sustain as every new requirement adds more data points, more variations across markets, and more synchronization between systems. Consequently, if your process relies on spreadsheets, disconnected tools, or manual artwork updates, the risk compounds quickly.

This is why labeling continues to be a leading cause of recalls – because teams lack expertise, but because the system they operate in cannot scale with the volume of change. 

The Real Priority for 2026: Readiness, Not Reaction

The organizations that will succeed in this environment aren’t the ones reacting fastest to each regulation, but the ones that have built systems capable of absorbing change continuously.

That means centralizing labeling data into a single source of truth, automating artwork generation and updates, and ensuring full traceability across products and markets. In other words, it means moving from compliance firefighting to operational readiness.

A Practical Guide to Getting Prepared

To help medical device teams navigate this shift, we’ve created a new guide: “Get Proactive and Futureproof your Medical Device Labeling Process”. It breaks down:

• What these regulatory changes mean in practice
• Why manual processes are becoming a liability
• How to build a scalable, future-ready labeling operation

If you’re responsible for regulatory, labeling, quality, or packaging, this guide will give you a clear roadmap for what comes next because regulatory change isn't going to slow down. Now is the time to assess where your risks are and how prepared your organization really is. Download the free guide below to understand what’s coming and how to stay ahead of it.

Download the guide

Subscribe to our newsletter for all the latest label and artwork news

Today’s global and digital economy depends on clear product identification and easy information sharing. For regulated industries such as pharmaceuticals, medical devices, and cosmetics, this isn’t just about efficiency, but also patient safety, compliance, and trust. That’s where GS1 standards come in, so let's break down what they are, why they matter and how they affect labeling and artwork management.

Understanding GS1 Standards

GS1 is a global, not-for-profit organization that develops and maintains standards for business communication. Its most widely recognized standard is the barcode, but GS1 standards go far beyond that — they provide a universal language for identifying products, locations, assets, and logistics units throughout the supply chain.

Some of the most common GS1 identifiers include:

• GTIN (Global Trade Item Number): Identifies individual products or SKUs.
• GLN (Global Location Number): Identifies physical locations or legal entities (e.g., manufacturing plants, warehouses).
• SSCC (Serial Shipping Container Code): Identifies logistics units like pallets or cases.
• GS1 DataMatrix and QR Codes: Encode rich, structured data (such as expiry dates or batch numbers) in a compact format.

Together, these identifiers enable traceability, interoperability, and data accuracy across every participant in a global supply chain — from manufacturer to regulator to end user.

Why GS1 Standards Matter for Regulated Industries

In highly regulated sectors, the correct use of GS1 identifiers is a necessity for complete compliance and the safety of all involved. Here are some of the most important things to understand:

1. Ensuring Traceability and Patient Safety
Every product must be traceable from production to patient. GS1 standards underpin systems that track each unit’s journey, allowing for quick recalls, expiry management, and counterfeit prevention. For example, under the EU Falsified Medicines Directive (FMD) or the U.S. DSCSA (Drug Supply Chain Security Act), serialization using GS1 identifiers ensures that every package can be uniquely identified and verified.

2. Supporting Regulatory Requirements
Regulators across the world, including the FDA, EMA, and MHRA, endorse GS1 standards for labeling and serialization. Using GS1 data structures correctly is vital to meet UDI (Unique Device Identification) and pharmaceutical labeling mandates.

3. Driving Global Interoperability
Because GS1 standards are recognized globally, they simplify cross-border operations and ensure data consistency between trading partners, healthcare providers, and regulators. This is particularly important for multinational organizations operating under different regulatory regimes.

4. Reducing Risk Through Standardization
Using standardized identifiers minimizes the risk of labeling errors, which can have serious consequences — from product recalls to regulatory fines and, in worst cases, patient harm. GS1’s globally harmonized system ensures every product carries accurate, meaningful information.

The Role of Labeling and Artwork Management Software

Implementing GS1 standards demands robust systems and processes that manage product data, control artwork, and maintain compliance at every stage. This involves:

1. Data Integrity and Centralization
Modern labeling and artwork management platforms, such as Kallik’s, centralize master data and ensure that GS1 identifiers (like GTINs or GLNs) are accurate, validated, and consistently applied. This eliminates the risk of using outdated or incorrect codes during label design.

2. Automation and Rule-Based Compliance
Automation ensures that GS1 identifiers and barcode structures are applied correctly across thousands of SKUs. Rule-based workflows verify data at every stage, so compliance is baked into the process rather than checked after the fact.

3. Visibility and Auditability
Regulated industries must be able to demonstrate compliance during audits. A digital artwork and labeling system provides full version control, approval workflows, and audit trails, ensuring every label change can be tracked back to its source.

4. Adaptability to Change
As GS1 standards evolve (for example, the transition to 2D barcodes and GS1 Digital Link), flexible labeling systems allow organizations to adapt quickly without disrupting supply chains or re-engineering entire labeling templates.

The Bottom Line: Compliance Starts with Standards

GS1 standards are the foundation of trust and traceability in regulated industries. But compliance depends on the right tools to enforce them at scale. By integrating GS1 principles into labeling and artwork management software, organizations can ensure that every product label not only meets global regulatory requirements but also delivers on its ultimate purpose: protecting patients, consumers, and brands alike.

Interested in learning how Kallik helps organizations achieve complete regulatory compliance with zero errors and total consistency? Contact us here or check out our case studies to see real world examples of how we've helped some of the biggest global manufacturers.

Read our FREE digital transformation guide

We're Giving Away Five Amazon Vouchers for Answering our 2025/2026 Labeling Survey!

We’re currently running a short industry survey on labeling and artwork challenges for 2026, and we’d really appreciate your input! Your insights could help shape our upcoming 2026 industry report. If you can spare five minutes, take the survey and enter our draw for one of five $/£50 Amazon vouchers.

Fill in the survey

When it comes to medical device manufacturing, labeling accuracy and compliance are non-negotiable. As global operations expand and regulatory frameworks become more complex, manufacturers are increasingly turning to automated labeling systems to streamline processes, eliminate human error, and ensure global consistency.

This article explores the core benefits of implementing an automated labeling system across global manufacturing environments, and how it supports compliance with stringent regulations like EU MDR, FDA 21 CFR Part 11, and UDI labeling requirements.

1. Ensuring Global Compliance with Medical Device Regulations

Every medical device label must meet specific regulatory standards, and these vary across regions. Whether it’s UDI compliance in the United States, EU MDR labeling requirements in Europe, or ISO 13485 quality management systems, maintaining accuracy across geographies is a challenge for any manufacturer.

An automated labeling system ensures that compliance rules are built directly into the labeling process. This allows medical device companies to:

• Automatically apply region-specific labeling templates
• Maintain full audit trails for regulatory inspections
• Reduce noncompliance risk through controlled label versioning

With built-in validation and electronic signatures that align with FDA 21 CFR Part 11, an automated labeling system makes it easier to meet global regulatory obligations while minimizing manual intervention.

2. Improved Accuracy and Error Reduction

Manual labeling introduces risk. A single misprint or incorrect data field can lead to product recalls, compliance violations, and costly downtime. An automated labeling system eliminates these risks by integrating directly with master data systems such as ERP, MES, and PLM platforms.

By connecting to centralized data sources, automated labeling systems automatically populate variable data like lot numbers, expiration dates, and device identifiers. This removes the need for manual entry and ensures 100% accuracy every time a label is printed.

3. Accelerated Global Production and Time-to-Market

Label changes must often be executed quickly to respond to new regulations, product updates, or market launches. Automated labeling systems enable centralized label management, allowing updates to be deployed instantly across global facilities.

This then reduces label change cycles from weeks to just minutes, consequently accelerating approvals and helping manufacturers bring products to market faster. For medical device companies navigating multiple regions and product variations, an automated labeling system becomes an operational game-changer.

4. Enhanced Traceability and UDI Compliance

Traceability is critical in medical device labeling. The UDI (Unique Device Identification) system requires consistent and standardized labeling that enables rapid identification throughout the product lifecycle.

An automated labeling system can support this by:

• Generating UDI-compliant barcodes and data matrices automatically
• Integrating with device registration databases
• Providing instant access to complete label histories

This not only ensures compliance with FDA UDI and EU MDR but also strengthens internal quality control and post-market surveillance.

5. Reduced Costs and Operational Efficiency

By removing manual tasks and minimizing rework, automated labeling systems reduce operational costs across the production line. They streamline label design, approval, and printing, all while maintaining compliance and consistency across global sites.

When deployed at scale, an automated labeling system drives measurable ROI through:

• Decreased downtime from labeling errors
• Reduced waste from misprinted labels
• Simplified IT maintenance and validation processes

In short, automation transforms labeling from a compliance burden into a strategic advantage.

6. Future-Proofing Through Scalability and Integration

As the global medical device industry continues to evolve, manufacturers need labeling systems that can scale and adapt. Modern automated labeling systems are built with flexibility in mind, integrating seamlessly with digital ecosystems and cloud-based architectures. This means future updates, such as new barcode standards, multi-language labeling, or expanded UDI regulations, can be implemented quickly without disrupting operations.

Final Thoughts

For global medical device manufacturers, labeling is crucial for operational integrity and brand trust. By implementing a robust automated labeling system, organizations can ensure accuracy, accelerate production, and maintain compliance across every market.

As regulatory scrutiny increases and supply chains become more complex, automated labeling systems provide the control, scalability, and transparency manufacturers need to stay ahead. And if you’re considering making the change but aren’t sure where to start or feel unprepared, you can download our latest ebook on getting into the mindset for digital transformation here.  Alternatively, speak to one of our labeling and artwork experts to learn more about what Veraciti™ can do for your business, by calling +44 (0) 1827 318100 or emailing enquiries@kallik.com.

View your FREE guide

We're Giving Away Five Amazon Vouchers for Answering our 2025/2026 Labeling Survey!

We’re currently running a short industry survey on labeling and artwork challenges for 2026, and we’d really appreciate your input! Your insights could help shape our upcoming 2026 industry report. If you can spare five minutes, take the survey and enter our draw for one of five $/£50 Amazon vouchers.

Fill in the survey

At Kallik, we pride ourselves on staying close to the challenges, conversations, and innovations shaping the future of labeling and packaging. That means more than just keeping up with industry news, but being part of the dialogue.

In recent weeks, two of our team members represented Kallik at major industry events: Kallik’s Chief Delivery Officer, Beth Peckover, attended the 14th Pharma Packaging and Labeling Innovation Forum in Berlin, while Senior Vice President of Sales, Sharad Khusal, joined the virtual Q1 Productions 16th Semi-Annual Medical Device & Diagnostic Labeling Conference.

Both events offered a wealth of insight into where the pharmaceutical and medical device sectors are heading and what that means for labeling, artwork, and packaging operations. Below, we recap the major themes that emerged and look at how to stay one step ahead.

The Big Talking Point: ePI and the Digital Transformation of Labeling

One of the most prominent topics at the Berlin forum was electronic Product Information (ePI). As Beth shared, ePI was the subject of multiple discussions and presentations, and it’s clear why.

ePI represents the digital evolution of medical information, where product leaflets, patient information, and label content are made available electronically, typically via QR codes or online portals. The European Medicines Agency (EMA) is leading the way with pilot programs exploring how this digital approach can improve patient access, enable faster updates, and support more sustainable, paperless labeling.

While the concept may sound straightforward, the implications for labeling and artwork are significant. ePI requires content to be managed in structured, modular formats rather than as static documents. Every change, whether a dosage update or a new safety warning, needs to be reflected instantly across both printed and digital formats.

That demands a high level of content agility, data accuracy, and process integration. For artwork and labeling teams, this means rethinking how they manage product information: moving from manual updates to centralized, automated systems that ensure every label, leaflet, and QR code is perfectly in sync.

As the industry transitions toward digital-first product information, companies will need to strike a careful balance between compliance, accessibility, and user experience. At Kallik, we see this as a huge opportunity for organizations to modernize their labeling operations, reduce risk, and streamline updates, while ensuring the same quality and consistency across every channel.

Pharma Supply Chain Pressures and the Need for Agility

Another major theme Beth noted at the Berlin event was the growing challenge of supply chain disruption in the pharmaceutical industry. Shortages of key materials and ingredients are forcing companies to source from alternative suppliers at short notice.

That might sound like a procurement issue, but it has deep implications for packaging and labeling. When suppliers or components change, the product specifications often change too. This ultimately means labels and artwork must be adapted quickly to reflect new details, batch information, or manufacturing locations.

This is where agility in packaging and labeling becomes critical. Companies that rely on manual updates, spreadsheets, or disjointed approval processes risk significant delays, inconsistencies, and even compliance breaches.

The takeaway from the forum was clear: businesses need flexible, responsive labeling systems that can handle change efficiently. Whether that’s updating artwork across multiple SKUs or localizing information for different markets, agility must be built into the process and not bolted on as an afterthought.
Beth comments on this, “At Kallik, we’ve long emphasized the importance of flexibility. True agility in labeling comes from centralized data, automation, and digital collaboration, allowing changes to cascade instantly across all materials while maintaining full traceability and compliance.”

Medical Device Labeling: Integration, Security, and Global Flexibility

Meanwhile, over at the Q1 Productions event, Sharad found that the conversations around medical device labeling echoed similar themes of agility and digital maturity.

One key area of interest was interoperability: the ability for labeling content to integrate seamlessly with other systems. Delegates were particularly keen to understand how digital labeling solutions can support standardized data formats and integrations with enterprise systems such as PLM, ERP, and regulatory databases.

This reflects a growing recognition that labeling no longer operates in isolation. To achieve efficiency and compliance at scale, it must connect directly to the systems that feed it data to ensure a single, authoritative source of truth.

Sharad shares, “Following my presentation, I received questions about the types of label formats supported by modern labeling platforms, especially around flexibility and customization.” Many companies face the challenge of managing region-specific label variations to meet different country regulations and language requirements. This is why it’s crucial to use a platform that can handle this diversity while still maintaining consistency and control.

Another recurring topic was cybersecurity. As more labeling operations move to the cloud, delegates were rightly concerned about data protection, malicious attacks, and the safeguarding of intellectual property. The message from attendees was clear: labeling vendors must not only deliver flexibility and integration but also ensure that cloud-based environments meet the highest security standards.

A Clear Message: The Industry Wants Confidence and Control

Across both conferences, the common thread was unmistakable. Whether it’s ePI in pharma, supply chain agility, or digitized labeling in the medical device space, organizations are looking for confidence and control. They want systems that allow them to adapt quickly, maintain compliance, and collaborate securely without sacrificing quality or speed.

It’s encouraging to see the industry aligning around these priorities. As labeling becomes more interconnected with wider digital ecosystems, the focus is shifting from reactive problem-solving to proactive transformation. Businesses are looking not just to comply with regulations but to future-proof their labeling operations for the next wave of change.

How Veraciti™ Supports This Digital Labeling Future

These are exactly the challenges that Veraciti™, Kallik’s enterprise labeling and artwork management platform, was built to solve. Veraciti™ provides a single, centralized hub for managing labeling content across all markets, products, and packaging types.

It enables full traceability, ensuring every change is controlled, approved, and published accurately. With automated workflows, content reuse, and structured data management, Veraciti™ gives organizations the agility they need to respond to supply chain changes, regulatory updates, or global variations without introducing risk.

Its cloud-based architecture offers the highest levels of security and scalability, allowing global teams to collaborate in real time while protecting sensitive information. And as the industry moves toward digital standards such as ePI, Veraciti™ is ready and supporting structured content formats and integrations that will help companies transition confidently into the digital labeling era.

Looking Ahead

The conversations at both conferences reinforced what we already know: the pace of change in pharmaceutical and medical device labeling is accelerating. New regulations, digital standards, and supply chain challenges are rewriting the rules - but they’re also opening the door to smarter, more efficient ways of working. At Kallik, we’re proud to be ahead of the game with this, offering some of the world’s largest organizations the solution to all their labeling and artwork needs, all in one single, cloud-based platform.

If you’d like to learn more about how Veraciti™ can help your organization adapt to these industry shifts, get in touch with our team by calling +44 (0) 1827 318100 or emailing enquiries@kallik.com.

Moving Beyond Compliance: How Digitalized Labeling Strengthens Supply Chains and Patient Trust

From Compliance to Maturity

It has been several years since the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) came into effect. By now, most medical device manufacturers are familiar with Unique Device Identification (UDI) requirements and the EUDAMED database.

Yet, many organizations continue to face the same challenges:

• Fragmented supply chains with siloed labeling processes
• Difficulty maintaining a single source of truth across global markets
• Slow, costly updates when regulations or safety information change
• The ongoing shift to e-labeling and digital-first communication

In 2025, the conversation is no longer about what UDI is — it’s about how to embed digitalized labeling into core business processes and unlock real efficiency and trust.

The Case for Digitalized Labeling

Even though compliance is mandatory, labeling doesn’t need to be a cost center. By digitalizing labeling and artwork management, medical device companies can achieve:

Consistency: one authoritative master source for all content, across packaging, IFUs, and e-labels

Speed: instant updates to meet regulatory changes or safety updates

Transparency: end-to-end visibility and auditability across the supply chain

Efficiency: reduced duplication, faster approvals, lower costs

Interoperability & Global Readiness

While the basics of UDI are now standard practice, achieving global interoperability remains a challenge. Manufacturers must:

• Adapt labeling for different regional requirements while preserving accuracy
• Manage translations at scale without introducing errors
• Ensure full traceability back to the master content source

Companies relying on local systems or manual PDF-based processes struggle here — leaving them exposed to compliance risks and inefficiencies.

E-Labeling: The Next Competitive Frontier

Regulators now support electronic Instructions for Use (eIFUs), and adoption is accelerating. Patients and healthcare providers increasingly expect digital-first access to safety and usage information.

Organizations embracing e-labeling gain:

• Faster, more cost-effective content updates
• Reduced reliance on print production and distribution
• A more sustainable and modern approach to information delivery
• Greater trust from patients and healthcare providers who can access accurate, up-to-date content instantly

Overcoming Legacy Barriers

Many organizations still rely on outdated, fragmented labeling processes:

• Content locked in PDFs, print files, or emails
• Disconnected local printing systems
• Unclear ownership of data governance

These barriers prevent agility and make compliance more costly. The solution is to manage labeling at the atomic level — symbols, text, and data elements stored centrally and reused seamlessly across markets and formats.

How Kallik Helps in 2025

Kallik’s enterprise labeling platform, Veraciti™, helps medical device companies move from compliance-driven processes to true digital maturity:

• A single, digital master source for all labeling content
• End-to-end traceability and interoperability across global supply chains
• Built-in support for e-labeling and patient access
• Scalable, cloud-based compliance for any format, in any territory

By embedding labeling into digital strategy, organizations can transform a regulatory requirement into a driver of efficiency, trust, and competitive advantage.

The Verdict?

In 2025, the question is no longer “What is UDI?” but “How can we use it to build stronger, smarter, and more trusted supply chains?” Digitalized labeling is the answer. And with Kallik, manufacturers can move confidently beyond compliance into a future of transparency, efficiency, and patient safety. Want to learn more about Veraciti? Book a one-to-one demo or speak to our team and discover how Kallik can help you take control of your labeling and artwork at scale.

Email: enquiries@kallik.com
Call: +44 (0) 1827 318100

The medical device industry is one of the most heavily regulated in the world, and for good reason, as labels directly impact the safety of both the patient and healthcare provider. Yet, with a constantly shifting global regulatory landscape, manufacturers face mounting challenges in ensuring compliance. From EU MDR and FDA UDI to IVDR and GS1 standards, keeping pace with requirements is critical. This blog explores the key frameworks, the risks of non-compliance, and why medical device labeling software is essential for managing complexity across markets.

Understanding Global Medical Device Labeling Requirements

Medical device labeling requirements vary significantly across regions, but share the same goal: ensuring accuracy, traceability, and patient safety. Below are the most important regulations manufacturers need to navigate.

What is EU MDR (Medical Device Regulation)?

The EU Medical Device Regulation (MDR) came into full effect in 2021, significantly increasing the scope and requirements for labeling. Manufacturers must ensure labels include information such as unique device identifiers (UDI), symbols for safe use, and clear translation into all EU member state languages. MDR also places emphasis on electronic labeling in certain cases, making digital readiness essential.

What is FDA UDI (Unique Device Identification)?

The U.S. Food and Drug Administration’s Unique Device Identification (UDI) system requires most medical devices to carry a unique identifier that can be tracked in the FDA’s Global Unique Device Identification Database (GUDID). This improves traceability, supports recalls, and strengthens patient safety initiatives. Compliance deadlines vary by device class, but enforcement is increasingly strict.

What is IVDR (In Vitro Diagnostic Regulation)?

For companies producing in vitro diagnostic devices, the IVDR brings a new layer of requirements. Labels must include comprehensive information on device performance, safety, and use, as well as UDI information for traceability. Like MDR, it also mandates translations and standardized symbols to ensure global usability.

What Are GS1 Standards?

While not a regulation, GS1 standards play a critical role in global medical device labeling compliance. GS1 barcodes and identifiers are widely recognized across healthcare supply chains, ensuring interoperability between manufacturers, distributors, hospitals, and regulators. Many regulatory bodies, including the FDA and EU authorities, require UDIs to be GS1-compliant.

Other Regional Frameworks

• Health Canada has its own device labeling requirements, closely aligned with UDI initiatives.
• China’s NMPA has implemented UDI rules for specific classes of medical devices.
• Japan’s PMDA also mandates labeling standards that align with global UDI frameworks.

For multinational manufacturers, this means labeling compliance is not a one-time exercise but an ongoing, global challenge.

The Risks of Non-Compliance in Medical Device Labeling

Failing to meet medical device labeling compliance standards carries severe consequences:

• Non-compliant labels can lead to fines, forced product withdrawals, and reputational damage.
• A label that doesn’t meet regional requirements may prevent or delay market entry.
• Mislabeling or lack of traceability can directly endanger patients, which is the core reason behind strict regulations.
• Fragmented labeling processes create bottlenecks, increasing the risk of human error and slowing product launches.

How Medical Device Labeling Software Simplifies Global Compliance

To manage this complexity, manufacturers are turning to medical device labeling software as a centralized solution.

Key benefits include:

• Centralized control: A single source of truth for all label data ensures consistency across global markets.
• Automated compliance updates: Built-in rules and templates aligned with regulations like EU MDR, FDA UDI, and IVDR reduce manual effort.
• Global scalability: The ability to manage multi-language translations and region-specific requirements from one platform.
• Integration with supply chains: GS1-compliant barcodes and identifiers ensure interoperability with regulators and healthcare partners.
• Audit readiness: Complete version control and traceability simplify audits and inspections.

In an era where regulatory complexity is only increasing, investing in robust medical device labeling software is no longer optional, but integral to the success of your business.

Future-Proofing Medical Device Labeling Compliance

Global medical device labeling requirements are evolving rapidly, and the risks of falling behind are too high. By understanding frameworks like EU MDR, FDA UDI, IVDR, and GS1 standards, manufacturers can better anticipate compliance challenges. But true resilience comes from adopting medical device labeling software that centralizes, automates, and streamlines compliance efforts.

For manufacturers, this is not just about ticking boxes; it’s about safeguarding patient safety, protecting brand reputation, and ensuring continued access to global markets.

See what Kallik can do for your business with a future-proof, end-to-end, fully digital labeling process. Speak to one of our experts today by calling +44 (0) 1827 318100 or emailing enquiries@kallik.com. 

View the brochure

The EU MDR continues to evolve and so do its implications for labeling and artwork. The European Commission’s latest update (August 2025) revises national EU MDR labeling requirements, this time focusing on Portugal. While this may seem like a small change, it highlights a much bigger challenge for global manufacturers: keeping pace with shifting, country-specific rules across Europe.

What’s Changed in The Latest EU MDR Update?

• Portugal now requires Portuguese for all core documentation, including labels, IFUs, and implant cards.

• English may still be used for professional users or GUI interfaces, but only under strict conditions:

            - Portuguese IFUs must still be available (including translations of any GUI content). 
           - No evidence of incidents or complaints linked to English-only usage can exist.

This follows earlier updates for France (2024) and Romania (2024), demonstrating that EU MDR regulations, particularly around language, are constantly being refined.

What Do Manufacturers Need to Do 

For manufacturers, this isn’t just a translation issue, but a compliance and risk management challenge:

• Multiple regimes to track: Each EU Member State can enforce its own language rules under EU MDR regulations.
• Digital touchpoints included: GUIs, apps, and digital instructions are all subject to EU MDR labeling requirements.
• Risk of non-compliance: Missteps can mean rejected submissions, product recalls, or reputational damage.

In practice, this means labeling and artwork processes must go beyond static packaging — they need to be dynamic, multi-language, and fully auditable.

How Kallik's Cloud-Based, End-to-End Labeling and Artwork Software Can Help

Kallik’s Veraciti is designed for exactly this type of regulatory complexity. By providing a centralized source of truth for all label content across countries and languages, it ensures consistency and control. Its automated workflows apply country-specific EU MDR labeling requirements directly to artwork, labels, IFUs, and GUIs, removing the risk of manual error. At the same time, Veraciti delivers audit-ready compliance with full version control and traceability for every language update, giving manufacturers the confidence that nothing is overlooked. And when national provisions shift under EU MDR regulations, Veraciti enables fast, accurate updates across entire product portfolios, allowing companies to stay ahead of change rather than scrambling to catch up.

The EU MDR will continue to evolve, and language requirements are just one piece of the puzzle. As more countries refine their expectations, organizations without a robust system will face rising costs, slower approvals, and higher compliance risks. With Veraciti, you don’t just react to new and updated regulations; you stay one step ahead. 

Want to Know More About the Leading Labeling and Artwork Software Recommended by Gartner?

Here at Kallik, our experts are here to help businesses stay ahead of the curve, building labeling and artwork processes that are agile, compliant, and future-ready. Get in touch with us today by emailing enquiries@kallik.com or calling +44 (0) 1827 318100. Alternatively, click here to contact us and see what our software can do for your business. Want to stay up to date with all the latest industry news to keep ahead of regulatory changes? Scroll to the bottom to sign up for our bi-monthly newsletter to get all the info you need, directly in your inbox!